Browse by Journal (V体育平台登录)

Amaral, P. et al VSports. (2025) Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia. Leukemia, (doi: 10. 1038/s41375-025-02723-2) (PMID:40813621) (Early Online Publication) .

Sun, J. et al. (2024) IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma VSports app下载. Leukemia, 38(11), pp. 2355-2365. (doi: 10. 1038/s41375-024-02391-8) (PMID:39215060) (PMCID:PMC11518999) .

Innes, A. I. et al. (2024) Impact of BCR::ABL1 single nucleotide variants on asciminib efficacy. Leukemia, 38(11), pp. 2443-2455. (doi: 10. 1038/s41375-024-02411-7) (PMID:39300220) (PMCID:PMC11518997) V体育官网.

Malik, Natasha ORCID: https://orcid. org/0000-0002-1768-3544, Hay, Jodie ORCID: https://orcid. org/0000-0002-2000-2578, Almuhanna, Hassan N. B. , VSports - Dunn, Karen M. , Lees, Jamie, Cassels, Jennifer, Li, Jiatian, Nakagawa, Rinako, Sansom, Owen J. ORCID: https://orcid. org/0000-0001-9540-3010 and V体育安卓版 - Michie, Alison M. ORCID: https://orcid. org/0000-0002-5404-475X (2023) mTORC1-selective activation of translation elongation promotes disease progression in chronic lymphocytic leukemia VSports手机版. Leukemia, 37, pp. 2414-2425. (doi: 10. 1038/s41375-023-02043-3) (PMID:37775560) (PMCID:PMC10681897) .

Cousins, A. et al. (2022) Central nervous system involvement in childhood acute lymphoblastic leukemia is linked to upregulation of cholesterol biosynthetic pathways. Leukemia, 36(12), pp. 2903-2907. (doi: 10 V体育安卓版. 1038/s41375-022-01722-x) (PMID:36289348) (PMCID:PMC9712090) .

Thastrup, Maria, Duguid, Alasdair, VSports最新版本 - Mirian, Christian, Schmiegelow, Kjeld and Halsey, Christina ORCID: https://orcid. org/0000-0001-5449-5246 (2022) Central nervous system involvement in childhood acute lymphoblastic leukemia: challenges and solutions. Leukemia, 36(12), pp. 2751-2768. (doi: 10 V体育ios版. 1038/s41375-022-01714-x) (PMID:36266325) .

Berndt, S. I. et al. (2022) Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia, 36(12), pp VSports最新版本. 2835-2844. (doi: 10. 1038/s41375-022-01711-0) (PMID:36273105) .

de Beauchamp, Lucie, Himonas, Ekaterini (V体育ios版) and Helgason, G. Vignir ORCID: https://orcid. org/0000-0003-1616-132X (2022) Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia. Leukemia, 36(1), pp V体育平台登录. 1-12. (doi: 10. 1038/s41375-021-01416-w) (PMID:34561557) (PMCID:PMC8727299) .

Zarou, Martha-Maria, Vazquez, Alexei ORCID: https://orcid. org/0000-0003-2764-3244 and Helgason, G. Vignir ORCID: https://orcid. org/0000-0003-1616-132X (2021) Folate metabolism: a re-emerging therapeutic target in haematological cancers. Leukemia, 35(6), pp VSports注册入口. 1539-1551. (doi: 10. 1038/s41375-021-01189-2) (PMID:33707653) .

Hsieh, Ya-Ching, Kirschner, Kristina ORCID: https://orcid. org/0000-0001-7607-8670 and Copland, Mhairi ORCID: https://orcid. org/0000-0002-7655-016X (2021) Improving outcomes in chronic myeloid leukemia through harnessing the immunological landscape. Leukemia, 35(5), pp V体育官网入口. 1229-1242. (doi: 10. 1038/s41375-021-01238-w) (PMID:33833387) (PMCID:PMC8102187) .

Horne, G. et al. (2020) A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease. Leukemia, 34(7), pp. 1775-1786. (doi: 10.1038/s41375-019-0700-9) (PMID:31925317) (PMCID:PMC7224085)

Kinstrie, R. et al. (2020) CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy. Leukemia, 34(6), pp. 1613-1625. (doi: 10.1038/s41375-019-0684-5) (PMID:31896780) (PMCID:PMC7272220)

Baquero, P. et al. (2019) Targeting quiescent leukemic stem cells using second generation autophagy inhibitors. Leukemia, 33(4), pp. 981-994. (doi: 10.1038/s41375-018-0252-4) (PMID:30185934) (PMCID:PMC6292500)

Smith, L. D. et al. (2019) BCR signaling contributes to autophagy regulation in chronic lymphocytic leukemia. Leukemia, 34, pp. 640-644. (doi: 10.1038/s41375-019-0557-y) (PMID:31462734) (PMCID:PMC6995694)

Cramer, S. D. et al. (2018) Mutant IL-7Rα and mutant NRas are sufficient to induce murine T cell acute lymphoblastic leukemia. Leukemia, 32, pp. 1795-1882. (doi: 10.1038/s41375-017-0001-0) (PMID:29535426) (PMCID:PMC7984718)

Weissinger, E.M. et al. (2017) The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation. Leukemia, 31(3), pp. 654-662. (doi: 10.1038/leu.2016.259) (PMID:27677743)

Oruganti, S.R., Torres, D.J., Krebsbach, S., Asperti-Boursin, F., Winters, J., "VSports手机版" Matlawska-Wasowska, K., Winter, S.S., "V体育官网" Halsey, C. ORCID: https://orcid.org/0000-0001-5449-5246 and Cannon, J.L. (2017) CARMA1 is a novel regulator of T-ALL disease and leukemic cell migration to the CNS. Leukemia, 31(1), pp. 255-258. (doi: 10.1038/leu.2016.272) (PMID:27698445)

Schemionek, M. et al. (2016) MTSS1 is a critical epigenetically regulated tumor suppressor in CML. Leukemia, 30(4), pp. 823-830. (doi: 10.1038/leu.2015.329) (PMID:26621336)

Middleton, O., Cosimo, E., Dobbin, E., McCaig, A.M., Clarke, C., Brant, A.M. (VSports手机版), Leach, M.T., Michie, A.M. ORCID: https://orcid.org/0000-0002-5404-475X and Wheadon, H. ORCID: https://orcid.org/0000-0001-9902-3170 (2015) Complement deficiencies limit CD20 monoclonal antibody treatment efficacy in CLL. Leukemia, 29(1), pp. 107-114. (doi: 10.1038/leu.2014.146) (PMID:24787488)

VSports在线直播 - Huang, X. ORCID: https://orcid.org/0000-0001-6706-199X, Spencer, G. J., Lynch, J.T., VSports注册入口 - Ciceri, F., Somerville, T.D.D. and Somervaille, T.C.P. (2014) Enhancers of Polycomb EPC1 and EPC2 sustain the oncogenic potential of MLL leukemia stem cells. Leukemia, 28(5), pp. 1081-1091. (doi: 10.1038/leu.2013.316)

Horvilleur, E. et al. (2014) A role for eukaryotic initiation factor 4B overexpression in the pathogenesis of diffuse large B-cell lymphoma. Leukemia, 28(5), pp. 1092-1102. (doi: 10.1038/leu.2013.295) (PMID:24135829) (PMCID:PMC4017261)

Lund, K. (VSports在线直播), Adams, P.D. and Copland, M. ORCID: https://orcid.org/0000-0002-7655-016X (2014) EZH2 in normal and malignant hematopoiesis. Leukemia, 28(1), pp. 44-49. (doi: 10.1038/leu.2013.288) (PMID:24097338)

Braig, M. et al. (2014) A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells. Leukemia, 28(10), pp. 2028-2039. (doi: 10.1038/leu.2014.95) (PMID:24603533)

Griaud, F., Pierce, A., Gonzalez Sanchez, M.B., VSports - Scott, M. ORCID: https://orcid.org/0000-0002-7177-6960, Abraham, S.A., Holyoake, T.L., "V体育平台登录" Tran, D.D.H., Tamura, T. (VSports注册入口) and Whetton, A.D. (2013) A pathway from leukemogenic oncogenes and stem cell chemokines to RNA processing via THOC5. Leukemia, 27(4), pp. 932-940. (doi: 10.1038/leu.2012.283)

"VSports注册入口" Preisinger, C., Schwarz, J.P., Bleijerveld, O.B., Corradini, E., Müller, P.J., Anderson, K.I., Kolch, W., "VSports注册入口" Scholten, A. and Heck, A.J.R. (2013) Imatinib-dependent tyrosine phosphorylation profiling of bcr-abl-positive chronic myeloid leukemia cells. Leukemia, 27(3), pp. 743-746. (doi: 10.1038/leu.2012.243)

Bommert, K.S. et al. (2013) The feed-forward loop between YB-1 and MYC is essential for multiple myeloma cell survival. Leukemia, 27(2), pp. 441-450. (doi: 10.1038/leu.2012.185)

Weissinger, E.M. et al. (2013) Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host-disease after allogeneic stem cell transplantation. Leukemia, (doi: 10.1038/leu.2013.210)

Zebisch, A. et al. (2012) Frequent loss of RAF kinase inhibitor protein expression in acute myeloid leukemia. Leukemia, 26(8), pp. 1842-1849. (doi: 10.1038/leu.2012.61)

Soliera, A.R. et al. (2012) Gfi-1 inhibits proliferation and colony formation of p210BCR/ABL-expressing cells via transcriptional repression of STAT 5 and Mcl-1. Leukemia, (doi: 10.1038/leu.2012.19) (PMID:22285998) (PMCID:PMC741684)

Pellicano, F., Simara, P., Sinclair, A. (VSports), Helgason, G.V. ORCID: https://orcid.org/0000-0003-1616-132X, Copland, M. ORCID: https://orcid.org/0000-0002-7655-016X, "V体育2025版" Grant, S. and Holyoake, T.L. (2011) The MEK inhibitor PD184352 enhances BMS-214662-induced apoptosis in CD34+ CML stem/progenitor cells. Leukemia, 25(7), pp. 1159-67. (doi: 10.1038/leu.2011.67)

Allan, E.K., Holyoake, T.L., Craig, A.R. and Jorgensen, H.G. (VSports最新版本) ORCID: https://orcid.org/0000-0003-4663-4191 (2011) Omacetaxine may have a role in chronic myeloid leukaemia eradication through downregulation of Mcl-1 and induction of apoptosis in stem/progenitor cells. Leukemia, 25(6), pp. 985-994. (doi: 10.1038/leu.2011.55)

Davies, A. et al. (2009) Nilotinib concentration in cell lines and primary CD34+ chronic myeloid leukemia cells is not mediated by active uptake or efflux by major drug transporters. Leukemia, 23(11), pp. 1999-2006. (doi: 10.1038/leu.2009.166)

Goldman, J.M. (V体育平台登录), Green, A.R., V体育安卓版 - Holyoake, T.L., Jamieson, C., Mesa, R. (V体育2025版), Mughal, T., Pellicano, F., Perrotti, D., Skoda, R. and Vannucchi, A.M. (2009) Chronic myeloproliferative diseases with and without the Ph chromosome: some unresolved issues. Leukemia, 23(10), pp. 1708-1715. (doi: 10.1038/leu.2009.142)

Drummond, M.W. et al. (2009) A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response. Leukemia, 23(6), pp. 1199-1201. (doi: 10.1038/leu.2009.43)

Allan, E.K., Hamilton, A., Hatziieremia, S., Zhou, P., V体育ios版 - Jorgensen, H.G. ORCID: https://orcid.org/0000-0003-4663-4191, Vigneri, P. and Holyoake, T.L. (2009) Nuclear entrapment of BCR-ABL by combining imatinib mesylate with leptomycin B does not eliminate CD34⁺ chronic myeloid leukaemia cells. Leukemia, 23(5), pp. 1006-1008. (doi: 10.1038/leu.2008.367)

Zebisch, A., Haller, M., Hiden, K., Goebel, T., Hoefler, G., "VSports app下载" Troppmair, J. and Sill, H. (2009) Loss of RAF kinase inhibitor protein is a somatic event in the pathogenesis of therapy-related acute myeloid leukemias with C-RAF germline mutations. Leukemia, 23(6), pp. 1049-1053. (doi: 10.1038/leu.2009.68)

Acharya, M., Edkins, A.L., Ozanne, B.W. and Cushley, W. (2009) SDF-1 and PDGF enhance [alpha]v[beta]5-mediated ERK activation and adhesion-independent growth of human pre-B cell lines. Leukemia, 23(10), pp. 1807-1817. (doi: 10.1038/leu.2009.126)

Feldman, E. et al. (2008) On the use of Lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia. Leukemia, 22(9), pp. 1707-1711. (doi: 10.1038/leu.2008.156)

Konig, H, Holtz, M, Modi, H, "V体育2025版" Manley, P, Holyoake, T (VSports注册入口), Forman, SJ and Bhatia, R (2008) Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors. Leukemia, 22(4), pp. 748-755. (doi: 10.1038/sj.leu.2405086)

Allan, E.K., Holyoake, T.L. and VSports最新版本 - Jorgensen, H.G. ORCID: https://orcid.org/0000-0003-4663-4191 (2006) Human neutrophil elastase is not a target for therapy in chronic myeloid leukaemia. Leukemia, 20(11), pp. 2054-2055. (doi: 10.1038/sj.leu.2404411)

Hamilton, A., Elrick, L., "VSports app下载" Myssina, S., Copland, M. (V体育平台登录) ORCID: https://orcid.org/0000-0002-7655-016X, Jorgensen, H.G. ORCID: https://orcid.org/0000-0003-4663-4191, Melo, J.V. and Holyoake, T.L. (2006) BCR-ABL activity and its response to drugs can be determined in CD34⁺ CML stem cells by CrkL phosphorylation status using flow cytometry. Leukemia, 20(6), pp. 1035-1039. (doi: 10.1038/sj.leu.2404189)

Allan, E.K., Eaves, C.J., "VSports" Elliott, M.A., Godden, J.L., Graham, S.M., Holyoake, T.L., Jorgensen, H.G. (V体育2025版) ORCID: https://orcid.org/0000-0003-4663-4191, Mountford, J.C. and Richmond, L. (2005) Lonafarnib reduces the resistance of primitive quiescent CML cells to imatinib mesylate in vitro. Leukemia, 19(7), pp. 1184-1191. (doi: 10.1038/sj.leu.2403785)

Eisterer, W. et al. (2005) Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease. Leukemia, 19(3), pp. 435-441. (doi: 10.1038/sj.leu.2403649)

Drummond, M.W., Hoare, S.F., Monaghan, A., Graham, S.M., Alcorn, M.J., VSports注册入口 - Keith, W.N. ORCID: https://orcid.org/0000-0001-7862-3580 and "V体育ios版" Holyoake, T.L. (2005) Dysregulated expression of the major telomerase components in leukaemic stem cells. Leukemia, 19(3), pp. 381-389. (doi: 10.1038/sj.leu.2403616)

Barber, K.E. et al. (2004) Amplification of the ABL gene in T-cell acute lymphoblastic leukemia. Leukemia, 18(6), pp. 1153-1156. (doi: 10.1038/sj.leu.2403357) (PMID:15057249)

"VSports" Jorgensen, H.G. ORCID: https://orcid.org/0000-0003-4663-4191, Allan, E.K., Jiang, X., Liakopoulou, E., Richmond, L., Eaves, C.J., Eaves, A.C. and Holyoake, T.L. (2003) Stage-specific alterations in serum levels of G-CSF in chronic myeloid leukaemia. Leukemia, 17(7), pp. 1430-1432. (doi: 10.1038/sj.leu.2402967)

"VSports" Chee, YL, Vickers, MA, "V体育2025版" Stevenson, D, V体育平台登录 - Holyoake, T and Culligan, J (2003) Fatal myelodysplastic syndrome developing during therapy with imatinib mesylate and characterised by the emergence of complex Philadelphia negative clones. Leukemia, 17(3), pp. 634-635. (doi: 10.1038/si.leu.2402842)

Drummond, MW, Lush, CJ, Vickers, MA, Reid, FM, Kaeda, J and Holyoake, T (2003) Imatinib mesylate-induced molecular remission of Philadelphia chromosome-positive myelodysplastic syndrome. Leukemia, 17(2), pp. 463-465. (doi: 10.1038/sj.leu.2402814)

Keeshan, K. ORCID: https://orcid.org/0000-0001-7266-0890, Cotter, T.G. and McKenna, S.L. (2002) High Bcr-Abl expression prevents the translocation of Bax and Bad to the mitochondrion. Leukemia, 16(9), pp. 1725-34.

Holyoake, T, Jiang, X, "V体育平台登录" Drummond, MW, Eaves, AC and Eaves, CJ (V体育平台登录) (2002) Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. Leukemia, 16(4), pp. 549-558. (doi: 10.1038/sj/leu/2402444)

Al Obaidi, M. et al. (2002) ETV6/AML1 fusion by FISH in adult acute lymphoblastic leukemia. Leukemia, 16, pp. 669-674. (doi: 10.1038/sj/leu/2402435)

Keeshan, K. ORCID: https://orcid.org/0000-0001-7266-0890, Mills, K.I., "VSports最新版本" Cotter, T.G. and McKenna, S.L. (2001) Elevated Bcr-Abl expression levels are sufficient for a haematopoietic cell line to acquire a drug-resistant phenotype. Leukemia, 15(12), pp. 1823-1833.

MacKenzie, J., Gallagher, A., Clayton, R.A., Perry, J., VSports手机版 - Eden, O.B., Ford, A.M., Greaves, M.F. and Jarrett, R.F. ORCID: https://orcid.org/0000-0003-0390-3478 (2001) Screening for herpesvirus genomes in common acute lymphoblastic leukemia. Leukemia, 15(3), pp. 415-421.

Neil, J. ORCID: https://orcid.org/0000-0003-4447-8279, Stewart, M., Terry, A., O'Hara, M., Hu, M., Blyth, K. ORCID: https://orcid.org/0000-0002-9304-439X, Baxter, E., Onions, D. and Cameron, E. (V体育官网入口) ORCID: https://orcid.org/0000-0001-8311-1491 (1999) Identification of murine CBF alpha1, a runt domain transcription factor, as a putative Myc collaborator in T cell lymphoma. Leukemia, 13(S1), S83-S86. (doi: 10.1038/sj.leu.2401295) (PMID:10232373)

Dadmarz, R. (VSports), V体育ios版 - Evans, T. ORCID: https://orcid.org/0000-0002-4140-6352, "V体育ios版" Secher, D., Marshall, N. and Cawley, J. (1987) Hairy cells possess more interferon receptors than other lymphoid cell types. Leukemia, 1(4), pp. 357-361. (PMID:2959825)